CN101370821A - 新型肽及其用途 - Google Patents
新型肽及其用途 Download PDFInfo
- Publication number
- CN101370821A CN101370821A CNA2006800526491A CN200680052649A CN101370821A CN 101370821 A CN101370821 A CN 101370821A CN A2006800526491 A CNA2006800526491 A CN A2006800526491A CN 200680052649 A CN200680052649 A CN 200680052649A CN 101370821 A CN101370821 A CN 101370821A
- Authority
- CN
- China
- Prior art keywords
- peptide
- aimp1
- seq
- present
- aminoacid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2006/000252 WO2007083853A1 (en) | 2006-01-23 | 2006-01-23 | Novel peptide and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101370821A true CN101370821A (zh) | 2009-02-18 |
CN101370821B CN101370821B (zh) | 2012-07-18 |
Family
ID=38287791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800526491A Active CN101370821B (zh) | 2006-01-23 | 2006-01-23 | 新型肽及其用途 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20090305973A1 (zh) |
EP (1) | EP1976864B1 (zh) |
JP (1) | JP5002603B2 (zh) |
KR (1) | KR101020658B1 (zh) |
CN (1) | CN101370821B (zh) |
AU (1) | AU2006335748A1 (zh) |
CA (1) | CA2640064A1 (zh) |
MX (1) | MX2008009493A (zh) |
WO (1) | WO2007083853A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101824083A (zh) * | 2009-03-06 | 2010-09-08 | 信谊药厂 | C端缺失型p43蛋白及其在肿瘤治疗药物中的应用 |
CN109715654A (zh) * | 2016-07-28 | 2019-05-03 | Curebio株式会社 | Aimp1蛋白的新片段和包含该片段的用于保护皮肤的组合物 |
CN109715655A (zh) * | 2016-07-28 | 2019-05-03 | Curebio株式会社 | Aimp1蛋白的新片段和包含该片段的用于促进毛发生长的组合物 |
CN111741968A (zh) * | 2019-01-25 | 2020-10-02 | Neomics 株式会社 | 具有皮肤增白活性的新型多肽及其用途 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007009368A (es) * | 2005-02-01 | 2008-01-14 | Imagene Co Ltd | Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos. |
WO2008086358A1 (en) | 2007-01-08 | 2008-07-17 | University Of Southern California Usc Stevens | Skin wound healing compositions and methods of use thereof |
WO2008094012A1 (en) * | 2007-02-01 | 2008-08-07 | Imagene Co., Ltd. | Novel polypeptide having anti-tumor activity |
DK3255146T3 (da) | 2009-03-16 | 2019-08-19 | Pangu Biopharma Ltd | Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter |
US8207118B2 (en) * | 2009-07-17 | 2012-06-26 | University Of Southern California | Skin wound healing compositions and methods of use thereof |
EP2509625B1 (en) | 2009-12-11 | 2015-01-28 | Atyr Pharma, Inc. | Histidyl trna synthetases for reducing inflammation |
JP6177129B2 (ja) | 2010-07-12 | 2017-08-09 | エータイアー ファーマ, インコーポレイテッド | ヒスチジルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
DK2635293T3 (en) * | 2010-11-03 | 2018-06-14 | Univ Southern California | Skin ulcer preparations and methods for their use |
US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
WO2013086216A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Improved aspartyl-trna synthetases |
AU2012368189B2 (en) | 2011-12-29 | 2017-08-31 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetase-Fc conjugates |
US8835387B2 (en) | 2012-02-16 | 2014-09-16 | Atyr Pharma, Inc. | Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases |
ES2708565T3 (es) | 2013-03-15 | 2019-04-10 | Atyr Pharma Inc | Conjugados de Fc-histidil-ARNt sintetasa |
US10995117B2 (en) | 2016-03-23 | 2021-05-04 | Kine Sciences Co., Ltd. | Peptide for skin regeneration or wound treatment and use thereof |
US10188694B2 (en) | 2016-03-23 | 2019-01-29 | Bio Pep Co., Ltd. | Peptide for skin regeneration or wound treatment and use thereof |
KR101996490B1 (ko) * | 2016-05-31 | 2019-07-03 | 인하대학교 산학협력단 | 간질환 예방 또는 치료용 펩타이드 및 이를 유효성분으로 포함하는 조성물 |
WO2018195338A1 (en) | 2017-04-20 | 2018-10-25 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
KR102024055B1 (ko) * | 2019-08-14 | 2019-09-24 | 주식회사 큐어바이오 | 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5155214A (en) * | 1984-03-05 | 1992-10-13 | The Salk Institute For Biological Studies | Basic fibroblast growth factor |
US5556645A (en) * | 1990-01-12 | 1996-09-17 | Bockman; Richard | Methods of enhancing wound healing and tissue repair |
US5886141A (en) * | 1990-10-26 | 1999-03-23 | Takeda Chemical Industries, Ltd. | Smooth muscle mitogen peptides and DNA coding therefor |
US5981606A (en) | 1991-03-01 | 1999-11-09 | Warner-Lambert Company | Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same |
US5149691A (en) | 1991-03-12 | 1992-09-22 | Creative Biomolecules, Inc. | Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone |
US5641867A (en) * | 1993-09-29 | 1997-06-24 | The Trustees Of Columbia University In The City Of New York | Antibody which specifically binds to endothelial-monocyte activating polypeptide II |
US6800286B1 (en) | 1998-08-19 | 2004-10-05 | The Regents Of The University Of Colorado | Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof |
MXPA01002875A (es) * | 1998-11-13 | 2002-04-08 | Los Angeles Childrens Hospital | Metodos para facilitar el crecimiento vascular. |
US6616648B2 (en) * | 2000-03-31 | 2003-09-09 | Sca Hygiene Products Ab | Absorbent article having v-shaped elastic attached to backsheet |
KR100405919B1 (ko) * | 2001-06-05 | 2003-11-14 | 주식회사 이매진 | p43의 N-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물 |
KR100515016B1 (ko) | 2002-07-22 | 2005-09-15 | 재단법인서울대학교산학협력재단 | p43을 유효성분으로 하는 창상 치료용 약학적 조성물 |
MX2007009368A (es) * | 2005-02-01 | 2008-01-14 | Imagene Co Ltd | Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos. |
WO2008094012A1 (en) * | 2007-02-01 | 2008-08-07 | Imagene Co., Ltd. | Novel polypeptide having anti-tumor activity |
-
2006
- 2006-01-23 CN CN2006800526491A patent/CN101370821B/zh active Active
- 2006-01-23 MX MX2008009493A patent/MX2008009493A/es active IP Right Grant
- 2006-01-23 WO PCT/KR2006/000252 patent/WO2007083853A1/en active Application Filing
- 2006-01-23 EP EP06702901A patent/EP1976864B1/en active Active
- 2006-01-23 AU AU2006335748A patent/AU2006335748A1/en not_active Abandoned
- 2006-01-23 JP JP2008552205A patent/JP5002603B2/ja active Active
- 2006-01-23 US US12/161,938 patent/US20090305973A1/en not_active Abandoned
- 2006-01-23 KR KR1020087017935A patent/KR101020658B1/ko active IP Right Grant
- 2006-01-23 CA CA002640064A patent/CA2640064A1/en not_active Abandoned
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101824083A (zh) * | 2009-03-06 | 2010-09-08 | 信谊药厂 | C端缺失型p43蛋白及其在肿瘤治疗药物中的应用 |
CN101824083B (zh) * | 2009-03-06 | 2014-01-15 | 信谊药厂 | C端缺失型p43蛋白及其在肿瘤治疗药物中的应用 |
CN109715654A (zh) * | 2016-07-28 | 2019-05-03 | Curebio株式会社 | Aimp1蛋白的新片段和包含该片段的用于保护皮肤的组合物 |
CN109715655A (zh) * | 2016-07-28 | 2019-05-03 | Curebio株式会社 | Aimp1蛋白的新片段和包含该片段的用于促进毛发生长的组合物 |
US11311601B2 (en) | 2016-07-28 | 2022-04-26 | Curebio Therapeutics | AIMP1 protein fragment and hair growth-promoting composition containing same as active ingredient |
CN109715655B (zh) * | 2016-07-28 | 2022-07-22 | Curebio疗法株式会社 | Aimp1蛋白的新片段和包含该片段的用于促进毛发生长的组合物 |
US11872263B2 (en) | 2016-07-28 | 2024-01-16 | Curebio Therapeutics | AIMP1 protein fragment and hair growth-promoting composition containing same as active ingredient |
CN111741968A (zh) * | 2019-01-25 | 2020-10-02 | Neomics 株式会社 | 具有皮肤增白活性的新型多肽及其用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2007083853A1 (en) | 2007-07-26 |
CN101370821B (zh) | 2012-07-18 |
KR101020658B1 (ko) | 2011-03-09 |
US20090305973A1 (en) | 2009-12-10 |
JP5002603B2 (ja) | 2012-08-15 |
KR20080103511A (ko) | 2008-11-27 |
AU2006335748A1 (en) | 2007-07-26 |
EP1976864A1 (en) | 2008-10-08 |
EP1976864A4 (en) | 2010-09-01 |
MX2008009493A (es) | 2008-10-03 |
EP1976864B1 (en) | 2012-09-26 |
JP2009523844A (ja) | 2009-06-25 |
CA2640064A1 (en) | 2007-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101370821B (zh) | 新型肽及其用途 | |
CA1223198A (en) | Repair of tissue in animals | |
EP2409988B1 (en) | Peptide fragments for inducing synthesis of extracellular matrix proteins | |
CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
EP0492614B1 (en) | Epitheliocyte growth accelerator | |
JPH03505870A (ja) | 傷治癒 | |
US8877713B2 (en) | Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same | |
US5510328A (en) | Compositions that inhibit wound contraction and methods of using same | |
Yang et al. | Effects of oral administration of peptides with low molecular weight from Alaska Pollock (Theragra chalcogramma) on cutaneous wound healing | |
US10864152B2 (en) | TRPV3 agonists for the treatment of skin conditions | |
Lightner | Tenascin: does it play a role in epidermal morphogenesis and homeostasis? | |
EP3442559B1 (en) | Bmp-7 derived peptides for use in a method of the treatment or prevention of osteoarthritis | |
CN113501870B (zh) | 一种乳源多肽及其嵌合肽在用于制备促进脂肪细胞能量代谢药物中的应用 | |
GB2321191A (en) | Peptides for use in wound treatment | |
CN102482323B (zh) | 新型肽及其应用 | |
US5851994A (en) | Compositions that inhibit wound contraction and methods of using same | |
EP2247300B1 (en) | Mntf peptide compositions and methods of use | |
EP0858808B1 (en) | Peptides for use in wound treatment | |
CA2404696C (en) | Medicament containing tissue inhibitor of metalloproteinases-2 (timp-2) as an osteoanabolically active substance | |
RU2008125167A (ru) | Терапевтическое средство для ускоренного заживления кожи, содержащее в качестве активного ингредиента дезацил-грелин и его производные | |
JPH0782172A (ja) | 創傷治療剤 | |
US10485846B2 (en) | Collagenase-derived peptides promote tissue regeneration and wound healing | |
US7129334B2 (en) | Synthetic peptide and uses for same | |
CN114957394B (zh) | 一种促皮肤修复多肽pm-7及应用 | |
EP2244719A1 (en) | Wound healing peptides and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NIERMICE CO., LTD. Free format text: FORMER OWNER: IMAGENE CO., LTD. Effective date: 20130620 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130620 Address after: Gyeonggi Do, South Korea Patentee after: MEDICINAL BIOCONVERGENCE RESEARCH CENTER Address before: Seoul, South Korea Patentee before: Imagene Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20171207 Address after: 2F834, Seoul, South Korea, the Olympic street in Jiangdong District Patentee after: Curebio Corporation Address before: Gyeonggi Do, South Korea Patentee before: MEDICINAL BIOCONVERGENCE RESEARCH CENTER |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211124 Address after: Gyeonggi Do Lingtong District South Korea Suwon Patentee after: Curebio therapeutics Co.,Ltd. Address before: 2F834, Seoul, South Korea, the Olympic street in Jiangdong District Patentee before: Curebio Corp. |